QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
ETR:AFX

Carl Zeiss Meditec (AFX) Stock Forecast, Price & News

€110.50
+0.15 (+0.14%)
(As of 06/6/2023 ET)
Compare
Today's Range
€110.15
€111.40
50-Day Range
€104.85
€128.00
52-Week Range
€101.75
€145.95
Volume
106,791 shs
Average Volume
94,405 shs
Market Capitalization
$9.88 billion
P/E Ratio
33.38
Dividend Yield
1.00%
Price Target
€167.50

AFX stock logo

About Carl Zeiss Meditec (ETR:AFX) Stock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

AFX Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?
See More Headlines

AFX Price History

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
4,624
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€167.50
High Stock Price Forecast
€195.00
Low Stock Price Forecast
€138.00
Forecasted Upside/Downside
+51.6%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$278.29 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.02 billion
Cash Flow
€0.08 per share
Book Value
€21.84 per share

Miscellaneous

Free Float
N/A
Market Cap
$9.88 billion
Optionable
Not Optionable
Beta
0.78

Key Executives

  • Dr. Markus Weber
    CEO & Chairman of Management Board
  • Mr. Justus Felix Wehmer (Age 58)
    CFO & Member of the Management Board
    Comp: $585.9k
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.
  • Dr. Euan S. Thomson Ph.D. (Age 60)
    Pres of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Bus. Unit
  • Mr. Magnus Reibenspiess
    Head of the Microsurgery Strategic Bus. Unit - ZEISS Medical Technology
  • Dr. Christian Munster (Age 52)
    Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board













AFX Stock - Frequently Asked Questions

What is Carl Zeiss Meditec's stock price forecast for 2023?

0 brokerages have issued twelve-month price objectives for Carl Zeiss Meditec's stock. Their AFX share price forecasts range from €138.00 to €195.00. On average, they anticipate the company's share price to reach €167.50 in the next year. This suggests a possible upside of 51.6% from the stock's current price.
View analysts price targets for AFX
or view top-rated stocks among Wall Street analysts.

How have AFX shares performed in 2023?

Carl Zeiss Meditec's stock was trading at €117.90 on January 1st, 2023. Since then, AFX shares have decreased by 6.3% and is now trading at €110.50.
View the best growth stocks for 2023 here
.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec (ETR:AFX) pays an annual dividend of €1.10 per share and currently has a dividend yield of 1.01%. The dividend payout ratio is 33.23%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €110.50.

How much money does Carl Zeiss Meditec make?

Carl Zeiss Meditec (ETR:AFX) has a market capitalization of $9.88 billion and generates $2.02 billion in revenue each year. The company earns $278.29 million in net income (profit) each year or €3.31 on an earnings per share basis.

How many employees does Carl Zeiss Meditec have?

The company employs 4,624 workers across the globe.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The official website for the company is www.zeiss.com. The company can be reached via phone at +49-3641-2200.

This page (ETR:AFX) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -